首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension.
【24h】

Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension.

机译:尿中性粒细胞明胶酶相关脂质运载蛋白(uNGAL)和白蛋白的组合使用作为原发性高血压早期心脏损害的标志物。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Neutrophil Gelatinase-Associated Lipocalin (NGAL) is an early and specific marker of acute kidney dysfunction. Recent evidences suggest that NGAL may also be involved in chronic vascular remodeling during the development of atherosclerosis. Albuminuria, a powerful predictor of cardiovascular events, is thought to reflect widespread subclinical vascular abnormalities. We investigated the relationship between urinary NGAL (uNGAL), albuminuria and left ventricular mass (LVM) in patients with primary hypertension. METHODS: A total of 120 untreated, non diabetic patients with primary hypertension (mean age 47 +/- 9 years) were studied. uNGAL was measured by a chemiluminescent microparticle method, optimized on a fully automated analytical platform (ARCHITECT, Abbott Diagnostics Inc, Rome, IT). Albuminuria was measured by immunonephelometry on an Immage Immunochemistry System (Beckman Coulter, Inc., Fullerton, California, USA) and expressed as albumin/creatinine ratio (ACR). LVM was assessed by echocardiography and indexed to body surface area (LVM/BSA). RESULTS: No significant correlation was found between uNGAL and ACR; however, both variables were directly related to clinic systolic blood pressure (rho=0.241, p=0.0085 and rho=0.248, p=0.0068 respectively), left ventricular relative wall thickness (rho=0.251, p=0.0156 and rho=0.263, p=0.0013 respectively), and LVM/BSA (rho=0.285, p=0.0062 and rho=0.213, p=0.0410 respectively). The uNGAL and ACR simultaneous increase above their respective median values was associated with higher LVM/BSA values (p=0.0109) and with a higher prevalence of left ventricular hypertrophy (LVH) (p=0.0017). Furthermore, logistic regression analysis showed that the risk of presenting LVH increased more than 4-fold when uNGAL and ACR were both above the median value, even after adjustment for age, gender and blood pressure values. CONCLUSIONS: The simultaneous increase in uNGAL and ACR excretion is significantly associated with the increase of LVM in low risk patients with primary hypertension. This association is clinically significant for the early assessment of cardiac damage in hypertension.
机译:背景:中性粒细胞明胶酶相关的脂蛋白(NGAL)是急性肾功能不全的早期和特异性标志物。最近的证据表明,NGAL还可能在动脉粥样硬化的发展过程中参与慢性血管重塑。蛋白尿是心血管事件的有力预测因子,被认为反映了广泛的亚临床血管异常。我们调查了原发性高血压患者的尿液NGAL(uNGAL),蛋白尿和左心室重量(LVM)之间的关系。方法:共研究了120名未经治疗的非糖尿病原发性高血压患者(平均年龄47 +/- 9岁)。通过化学发光微粒方法测量uNGAL,并在全自动分析平台(ARCHITECT,雅培诊断公司,罗马,IT)上进行了优化。在免疫免疫化学系统(Beckman Coulter,Inc.,Fullerton,California,USA)上通过免疫比浊法测量白蛋白尿,并以白蛋白/肌酸酐比(ACR)表示。 LVM通过超声心动图评估,并与体表面积(LVM / BSA)挂钩。结果:uNGAL和ACR之间没有发现显着相关性;然而,这两个变量均与临床收缩压(rho = 0.241,p = 0.0085和rho = 0.248,p = 0.0068),左心室相对壁厚(rho = 0.251,p = 0.0156和rho = 0.263,p)直接相关。分别为0.0013)和LVM / BSA(rho = 0.285,p = 0.0062和rho = 0.213,p = 0.0410)。 uNGAL和ACR同时升高到各自的中值以上与LVM / BSA值较高(p = 0.0109)和左室肥大(LVH)患病率较高(p = 0.0017)相关。此外,逻辑回归分析表明,即使在调整了年龄,性别和血压值之后,当uNGAL和ACR均高于中值时,出现LVH的风险增加了4倍以上。结论:低危原发性高血压患者中uNGAL和ACR排泄的同时增加与LVM的增加显着相关。该关联对高血压的心脏损害的早期评估具有临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号